BlackRock Fund Advisors’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $14.4M | Buy |
854,745
+97,272
| +13% | +$1.64M | ﹤0.01% | 2365 |
|
|
2016
Q3 | $12.4M | Buy |
757,473
+52,736
| +7% | +$865K | ﹤0.01% | 2338 |
|
|
2016
Q2 | $10.7M | Buy |
704,737
+117,550
| +20% | +$1.78M | ﹤0.01% | 2377 |
|
|
2016
Q1 | $8.49M | Buy |
587,187
+97,698
| +20% | +$1.41M | ﹤0.01% | 2454 |
|
|
2015
Q4 | $13.9M | Buy |
489,489
+230,928
| +89% | +$6.54M | ﹤0.01% | 2259 |
|
|
2015
Q3 | $4.33M | Sell |
258,561
-5,670
| -2% | -$94.9K | ﹤0.01% | 2869 |
|
|
2015
Q2 | $6.93M | Buy |
264,231
+185,111
| +234% | +$4.85M | ﹤0.01% | 2717 |
|
|
2015
Q1 | $1.38M | Sell |
79,120
-617
| -0.8% | -$10.8K | ﹤0.01% | 3187 |
|
|
2014
Q4 | $1.39M | Buy |
79,737
+16,072
| +25% | +$279K | ﹤0.01% | 3202 |
|
|
2014
Q3 | $1.19M | Sell |
63,665
-607
| -0.9% | -$11.3K | ﹤0.01% | 3182 |
|
|
2014
Q2 | $1.18M | Buy |
+64,272
| New | +$1.18M | ﹤0.01% | 3155 |
|